Literature DB >> 10481216

Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial.

W Scholz1, A Jessel, U Albus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10481216     DOI： 10.1023/a:1008998716063

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  22 in total

1.  Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H+ exchange.

Authors:  D Garcia-Dorado; M A González; J A Barrabés; M Ruiz-Meana; J Solares; R M Lidon; J Blanco; Y Puigfel; H M Piper; J Soler-Soler
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

2.  A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.

Authors: 
Journal:  N Engl J Med       Date:  1996-09-12       Impact factor: 91.245

3.  Infarct size limitation by a new Na(+)-H+ exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C.

Authors:  T Miura; T Ogawa; K Suzuki; M Goto; K Shimamoto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

4.  Antiarrhythmic effects of HOE642, a novel Na(+)-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts.

Authors:  Y X Xue; N N Aye; K Hashimoto
Journal:  Eur J Pharmacol       Date:  1996-12-19       Impact factor: 4.432

5.  Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart.

Authors:  A R Shipolini; H Yokoyama; M Galiñanes; S J Edmondson; D J Hearse; M Avkiran
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

6.  Time delay of cell death by Na+/H+-exchange inhibition in regionally ischemic, reperfused porcine hearts.

Authors:  H H Klein; R M Bohle; S Pich; S Lindert-Heimberg; J Wollenweber; K Nebendahl
Journal:  J Cardiovasc Pharmacol       Date:  1997-08       Impact factor: 3.105

7.  Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.

Authors: 
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

8.  New Na(+)-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart.

Authors:  M Hendrikx; K Mubagwa; F Verdonck; K Overloop; P Van Hecke; F Vanstapel; A Van Lommel; E Verbeken; J Lauweryns; W Flameng
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

9.  Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia.

Authors:  W Scholz; U Albus; H J Lang; W Linz; P A Martorana; H C Englert; B A Schölkens
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245
View more
  1 in total

Review 1.  NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.

Authors:  Wolfgang J Linz; Andreas E Busch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-19       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.